Nutrigenomics Market Growth $850.86 Million By 2025 With CAGR 16.48% | Grand View Research Inc.

Posted on 2019-08-26 by researchinsights in Biotech, Healthcare // 0 Comments

San Francisco, United States, 2019-Aug-26 — /EPR Network/ —

The global nutrigenomics market size is expected to reach USD 850.86 million by 2025 registering a CAGR of 16.48%, according to a new report by Grand View Research, Inc. This growth can be attributed to the rising cases of obesity and Cardiovascular Diseases (CVDs), particularly in developed regions. Nutrigenomics can play a vital role in the prevention of obesity by offering personalized, gene-based diet. Increased awareness about the product along with growing geriatric population will also augment the market growth.

Obesity and cancer research applications of nutrigenomics emerged as the market leaders in 2017 and are expected to maintain the dominance expanding at a significant CAGR over the forecast period. Developing regional markets including Asia Pacific, Latin America, and Middle East are also expected to witness rapid expansion owing to the increased cases of obesity and growing geriatric population.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/nutrigenomics-market

Further key findings from the study suggest:

The global nutrigenomics demand exceeded USD 250 million in 2017 and is expected to expand at a CAGR of 16.48% over the forecast period
Obesity application segment led the market in 2017 and is estimated to account for a 38% of the industry share by 2025
North America accounted for the largest market share in 2017 and is estimated to maintain its dominance over the years to come
The Asia Pacific market is projected to witness substantial growth over the next decade owing to increasing cases of obesity and CVD-related deaths
Key participants in the global nutrigenomics market include Koninklijke DSM N.V. (Royal DSM); BASF SE; Danone; GeneSmart; Unilever; Genova Diagnostics; Inc.; Nutrigenomix, Inc.; Metagenics, Inc.; WellGen, Inc.; and Cell Logic

Related Reports on Biotechnology:

Grand View Research has segmented the global nutrigenomics market on the basis of application and region:

Nutrigenomics Application Outlook (Revenue, USD Million, 2014 – 2025)

Obesity
Cardiovascular Diseases
Cancer Research

Nutrigenomics Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
- U.S.
- Canada
Europe
- Germany
- U.K.
Asia Pacific
- China
- Japan
Latin America
- Brazil
Middle East & Africa
- South Africa

For Press Release of This Research Report by Grand View Research:

https://www.grandviewresearch.com/press-release/global-nutrigenomics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Matched content

Editor’s pick